23 C
New York
Sunday, June 14, 2026

Tag: register

The North West Company Inc. Announces First Quarter Earnings and a Quarterly Dividend

WINNIPEG, Manitoba, June 09, 2026 (GLOBE NEWSWIRE) -- (TSX: NWC): The North West Company Inc. (the "Company" or "North West") today reported its unaudited financial results for the first quarter ended April 30, 2026. It also announced that the Board of Directors has declared a quarterly dividend of $0.41 to shareholders of record on June 30, 2026, to be paid on July 15, 2026.

Simon Property Group Announces Offering of Euro-Denominated Notes

INDIANAPOLIS, June 9, 2026 /PRNewswire/ -- Simon Property Group, L.P., a global leader in the ownership of premier shopping, dining, entertainment and mixed-use destinations (the...

Suja Life Reports First Quarter 2026 Financial Results

Net sales increased 22.5% year-over-year to $107.1 million

BE OPEN reveals the final two winners in the Design Equality with Innovation competition in support of SDG#5

LUGANO, Switzerland, June 9, 2026 /PRNewswire/ -- BE OPEN has identified the winners of the Public Vote and Founder's Choice Prizes in DESIGN EQUALITY with Innovation,...

CECO Environmental Provides Post-Closing Update on Thermon Transaction

Updates Full Year 2026 Outlook to Incorporate Combination
 Updates Full Year 2026 Outlook to Incorporate Combination

Vice President Pence Joins Robert Costa at the National Press Club on June 15

WASHINGTON, June 9, 2026 /PRNewswire/ -- Vice President Mike Pence will discuss his new book, "What Conservatives Believe," and detail his vision for the...

/R E P E A T –Media Advisory – PS Hogan to discuss North America’s energy advantage/

WASHINGTON, June 8, 2026 /CNW/ - Corey Hogan, Parliamentary Secretary to the Minister of Energy and Natural Resources, will participate in a discussion at...

Oculis to Present at the 47th Annual Goldman Sachs Global Healthcare Conference

ZUG, Switzerland, June 08, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing neuro-ophthalmic and ophthalmic diseases with significant unmet medical needs, announced today that Oculis’ management will participate in a fireside chat at the 47th Annual Goldman Sachs Global Healthcare Conference.  

EDWARD SMOLYANSKY, KEY LWAY SHAREHOLDER: TERMINATION OF POISON PILL MARKS IMPORTANT INFLECTION POINT FOR LIFEWAY SHAREHOLDERS AS GOVERNANCE QUESTIONS MOUNT AHEAD OF THE ELECTION

CHICAGO, June 8, 2026 /PRNewswire/ -- Edward Smolyansky, former Director and Chief Operating Officer of Lifeway Foods, Inc. (NASDAQ: LWAY) and the Company's largest shareholder,...

Yacht Club de Monaco accelerates transition to more responsible yachting

MONACO, June 08, 2026 (GLOBE NEWSWIRE) -- With the focus on World Oceans Day, Yacht Club de Monaco has an update on the initiatives it implements throughout the year to support the environmental transition in the yachting sector. Driven by the forward-looking vision of HSH Prince Albert II of Monaco, under the aegis of its ‘Monaco, Capital of Advanced Yachting’ approach, these actions are based on one simple conviction: that the sector’s future depends on concrete, measurable and collective solutions. At the heart of its strategy is the SEA Index® which has established itself as the benchmark tool for assessing and improving the environmental performance of yachts.

Key Industry Players Drive Competitive Landscape in High-End Refractometer Market

The global high-end refractometer market is set to expand from USD 0.23 billion in 2025 to USD 0.38 billion by 2032, achieving a CAGR of 7.3%. Growth is propelled by rising demand for precise measurements in pharmaceuticals, biotechnology, and more. IoT-enabled sensors and advanced temperature compensation are boosting applications in continuous manufacturing. The online/retail segment will be the fastest-growing sales channel, driven by a shift to digital procurement and B2B marketplaces. The Asia Pacific region will register the highest CAGR due to rapid industrialization. Key players like Anton Paar GmbH and METTLER TOLEDO dominate this evolving market landscape.
The global high-end refractometer market is set to expand from USD 0.23 billion in 2025 to USD 0.38 billion by 2032, achieving a CAGR of 7.3%. Growth is propelled by rising demand for precise measurements in pharmaceuticals, biotechnology, and more. IoT-enabled sensors and advanced temperature compensation are boosting applications in continuous manufacturing. The online/retail segment will be the fastest-growing sales channel, driven by a shift to digital procurement and B2B marketplaces. The Asia Pacific region will register the highest CAGR due to rapid industrialization. Key players like Anton Paar GmbH and METTLER TOLEDO dominate this evolving market landscape.

Long Ridge Energy LLC Announces Timing of First Quarter 2026 Earnings Conference Call

HANNIBAL, Ohio, June 08, 2026 (GLOBE NEWSWIRE) -- Long Ridge Energy LLC (“LRE”) is announcing its first quarter 2026 investor call for Thursday, June 11, 2026 at 3:00 PM ET. LRE comprises the electric power and natural gas business of Long Ridge Energy & Power LLC (“LREP”). LREP is a wholly owned portfolio company of FTAI Infrastructure, Inc. (Nasdaq: FIP). The conference call may be accessed by registering via the following link: https://register-conf.media-server.com/register/BI863a2ce8dbbb4ea0916ae4e6f81c8d7b. Once registered, participants will receive a dial-in and unique pin to access the call.

Provectus Biopharmaceuticals Announces Investor Webinar for 2026 Annual Meeting of Stockholders

KNOXVILLE, Tenn., June 08, 2026 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that its 2026 annual stockholder meeting (the “Annual Meeting”), including shareholder meeting activities and a company update, will be accessible by Zoom webinar (the “Webinar”). The in-person meeting will be held on Thursday, June 18, 2026 at Perkins Place Office Building, located at 525 Portland Street, Knoxville, Tenn., beginning at 4:00 p.m. Eastern Time.

Artiva Biotherapeutics Highlights AlloNK® Data Presented at EULAR 2026, FDA RMAT Designation in Refractory Rheumatoid Arthritis and Webcast Today

Artiva Biotherapeutics Highlights AlloNK® Data Presented at EULAR 2026, FDA RMAT Designation in Refractory Rheumatoid Arthritis and Webcast Today

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsRegister